Continuous and periodic expansion of CAG repeats in Huntington's disease R6/1 mice

Linda Møllersen1, Alexander D Rowe, Elisabeth Larsen

  • 1Centre for Molecular Biology and Neuroscience, Institute of Medical Microbiology, Oslo University Hospital, Oslo, Norway.

Plos Genetics
|December 21, 2010
PubMed

Insights

Huntington's disease involves CAG repeat expansion in brain cells. This study reveals distinct expansion patterns in different tissues, with irreversible, periodic expansions in the brain unlike other organs.

Area of Science:

  • Genetics
  • Neuroscience
  • Molecular Biology

Background:

  • Huntington's disease (HD) is a neurodegenerative disorder characterized by CAG repeat expansion in a specific gene.
  • Somatic CAG expansion varies by organ in HD, with the brain showing the highest instability and neuropathology.
  • Mechanisms of somatic CAG repeat instability are unclear, but DNA secondary structures during replication/repair are implicated.

Purpose of the Study:

  • To investigate the rates and modes of somatic CAG repeat expansion in different tissues of Huntington's disease R6/1 mice.
  • To elucidate the in vivo mechanisms underlying triplet repeat expansion in the brain versus other somatic tissues.

Main Methods:

  • Analysis of CAG repeat expansion rates and patterns in various tissues of Huntington's disease R6/1 mouse model.
  • Comparison of expansion dynamics between brain tissues (striatum, cortex) and peripheral tissues (tail).

Main Results:

  • Somatic tissues like the tail exhibit continuous, small expansions and contractions, suggesting frequent single-repeat changes.
  • Brain tissues, specifically the striatum and cortex, show dramatic, irreversible, and periodic CAG repeat expansions.
  • These periodic expansion profiles in the brain are a novel finding not previously reported.

Conclusions:

  • Mechanistically distinct processes drive CAG repeat expansion in different tissues of Huntington's disease models.
  • The brain's unique, periodic expansion pattern may be linked to its specific neuropathology.
  • Understanding these tissue-specific mechanisms is crucial for developing targeted HD therapies.